Fabrication and characterization of curcumin-releasing silk fibroin scaffold

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 7, 2012, Pages 1854-1866

  Kasoju, Naresh ^a   Bora, Utpal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

controlled release; curcumin; freeze thaw; scaffold; silk fibroin

Indexed keywords

BIOACTIVITY; CHEMOTHERAPY; DATA ENCAPSULATION; FABRICATION; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; FREEZING; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PORE SIZE; SCAFFOLDS; THAWING;

CONFORMATIONAL TRANSITIONS; CONTROLLED RELEASE; CURCUMIN; FABRICATION AND CHARACTERIZATIONS; FOURIER TRANSFORM INFRA REDS; FREEZE-THAW; NUCLEAR MAGNETIC RESONANCE STUDIES; SILK FIBROIN;

SCAFFOLDS (BIOLOGY);

CURCUMIN; CURCUMIN RELEASING SILK FIBROIN SCAFFOLD; FIBROIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; ESCHERICHIA COLI; FEMALE; FLUORESCENCE SPECTROSCOPY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; FREEZE THAWING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; POROSITY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; THERMOSTABILITY; X RAY DIFFRACTION;

EID: 84865990962     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32753     Document Type: Article

References (52)

1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H,. Curcumin: The Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75.
2. Mukherjee PK, Venkatesh P, Ponnusankar S,. Ethnopharmacology and integrative medicine-Let the history tell the future. J Ayurveda Integr Med 2010; 1: 100-109.
3. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V,. Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 2003; 28: 715-721.
4. Goel A, Kunnumakkara AB, Aggarwal BB,. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809.
5. Kulkarni SK, Dhir A,. An overview of curcumin in neurological disorders. Indian J Pharm Sci 2010; 72: 149-154.
6. Kohli K, Ali J, Ansari MJ, Raheman Z,. Curcumin: a natural antiinflammatory agent. Ann Indian J Pharmacol 2005; 37: 141-147.
7. Kesarvani RC, Khan AS,. An experimental study of wound healing by topical application of turmeric (Curcuma longa) paste on rats. Indian J Surg 1999; 61: 22-25.
8. Shaffrathul JH, Karthick PS, Rai R, Srinivas CR,. Turmeric: Role in hypertrichosis and acne. Indian J Dermatol 2007; 52: 116.
9. Mishra S, Palanivelu K,. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol 2008; 11: 13-19.
10. Soudamini KK, Kuttan R,. Cytotoxic and tumour reducing properties of curcumin. Indian J Pharmacol 1988; 20: 95-101.
11. Chaturvedi TP,. Uses of turmeric in dentistry: An update. Indian J Dent Res 2009; 20: 107-109.
12. Aggarwal BB, Sung B,. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 2009; 30: 85-94.
13. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC,. Multiple biological activities of curcumin: A short review. Life Sci 2006; 78: 2081-2087.
14. Joe B, Vijaykumar M, Lokesh BR,. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004; 44: 97-111.
15. Goel A, Jhurani S, Aggarwal BB,. Multi-targeted therapy by curcumin: How spicy is it? Mol. Nutr Food Res 2008; 52: 1010-1030.
16. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB,. Bioavailability of curcumin: Problems and promises. Mol Pharm 2007; 4: 807-818.
17. Bisht S, Maitra A,. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr Drug Discov Technol 2009; 6: 192-199.
18. Kumar V, Lewis SA, Mutalik S, Shenoy DB, Venkatesh UN,. Biodegradable microspheres of curcumin for treatment of inflammation. Indian J Physiol Pharmacol 2002; 46: 209-217.
19. Pan ChJ, Tang JJ, Weng YJ, Wang J, Huang N,. Preparation characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents. J Control Release 2006; 116: 42-49.
20. Dash AK, Cudworth GC,. 2nd. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998; 40: 1-12.
21. Chung HJ, Park TG,. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 2007; 59: 249-262.
22. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL,. Silk-based biomaterials. Biomaterials 2003; 24: 401-416.
23. Vepari C, Kaplan DL,. Silk as a biomaterial. Prog Polym Sci 2007; 32: 991-1007.
24. Numata K, Kaplan DL,. Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev 2010; 62: 1497-508.
25. Kasoju N, Bora U,. Silk fibroin based biomimetic artificial extracellular matrix for hepatic tissue engineering applications. Biomed Mater 2012; 7: 045004.
26. Kasoju N, Bora U,. Silk fibroin in tissue engineering. Adv Healthcare Mater 2012; DOI: 10.1002/adhm.201200097.
27. Uebersax L, Merkle HP, Meinel L,. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 2008; 127: 12-21.
28. Wenk E, Murphy AR, Kaplan DL, Meinel L, Merkle HP, Uebersax L,. The use of sulfonated silk fibroin derivatives to control binding delivery and potency of FGF-2 in tissue regeneration. Biomaterials 2010; 31: 1403-1413.
29. Uebersax L, Mattotti M, Papaloïzos M, Merkle HP, Gander B, Meinel L,. Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials 2007; 28: 4449-4460.
30. Bayraktar O, Malay O, Ozgarip Y, Batigün A,. Silk fibroin as a novel coating material for controlled release of theophylline. Eur J Pharm Biopharm 2005; 60: 373-381.
31. Pritchard EM, Szybala C, Boison D, Kaplan DL, Silk fibroin encapsulated powder reservoirs for sustained release of adenosine. J Control Release 2010; 144: 159-167.
32. Kim UJ, Park J, Kim HJ, Wada M, Kaplan DL,. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 2005; 26: 2775-2785.
33. Kasoju N, Bhonde RR, Bora U,. Preparation and characterization of Antheraea assama silk fibroin based novel non-woven scaffold for tissue engineering applications. J Tissue Eng Regen Med 2009; 3: 539-552.
34. Kasoju N, Bora U,. Antheraea assama silk fibroin-based functional scaffold with enhanced blood compatibility for tissue engineering applications. Adv Eng Mater 2010; 12: B139-B147.
35. Sahu A, Kasoju N, Bora U,. Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 2008; 9: 2905-2912.
36. Liang L, Tajmir-Riahi HA, Subirade M,. Interaction of β-lactoglobulin with resveratrol and its biological implications. Biomacromolecules 2008; 9: 50-56.
37. Hess S, Beek JV, Pannell LK,. Acid hydrolysis of silk fibroins and determination of the enrichment of isotopically labeled amino acids using precolumn derivatization and high-performance liquid chromatography-electrospray ionization-mass spectrometry. Anal Biochem 2001; 311: 19-26.
38. Das RK, Kasoju N, Bora U,. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine: NBM 2010; 6: 153-160.
39. Siepmann J, Peppas NA,. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139-157.
40. Peppas NA,. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985; 60: 110-111.
41. Sahu A, Kasoju N, Goswami P, Bora U,. Encapsulation of curcumin in pluronic block copolymer micelles for drug delivery applications. J Biomater Appl 2011; 25: 619-639.
42. Higuchi T,. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145-1149.
43. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA,. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 23-25.
44. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.
45. Zhu N, Wang Z,. An assay for DNA fragmentation in apoptosis without phenol/chloroform extraction and ethanol precipitation. Anal Biochem 1997; 246: 155-158.
46. Ali SS, Kasoju N, Luthra A, Singh A, Sharanabasava H, Sahu A, Bora U,. Indian medicinal herbs as sources of antioxidants. Food Res Int 2008; 41: 1-15.
47. Bhawana Basniwal RK, Buttar HS, Jain VK, Jain N,. Curcumin nanoparticles: Preparation characterization and antimicrobial study. J Agric Food Chem 2011; 59: 2056-2061.
48. Kasoju N, Bhonde RR, Bora U,. Fabrication of a novel micro-nano fibrous nonwoven scaffold with Antheraea assama silk fibroin for use in tissue engineering. Mater Lett 2009; 63: 2466-2469.
49. Suwantong O, Opanasopit P, Ruktanonchai U, Supaphol P,. Electrospun cellulose acetate fiber mats containing curcumin and release characteristic of the herbal substance. Polymer 2007; 48: 7546-7557.
50. Sahu A, Bora U, Kasoju N, Goswami P,. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 2008; 4: 1752-1761.
51. Tamada Y,. New process to form a silk fibroin porous 3-d structure. Biomacromolecules 2005; 6: 3100-3106.
52. Yang Y, Shao Z, Chen X, Zhou P,. Optical spectroscopy to investigate the structure of regenerated Bombyx mori silk fibroin in solution. Biomacromolecules 2004; 5: 773-779.